IMC-2C5 is a humanized antibody targeting PDGFRB/CD140b. IMC-2C5 binds with high affinity to PDGFRbeta and blocks its signaling pathway, thereby inhibiting tumor angiogenesis and stromal support, and exerting antitumor effects. IMC-2C5 is suitable for use in tumor research.
Purity:
100.00%
Target:
PDGFR
T9901A-227
* VAT and and shipping costs not included. Errors and price changes excepted
